Viagra Cost vs. Alternatives: Comparing Sildenafil to Every PDE5 Inhibitor in Class

At a glance
- Generic sildenafil 50 mg / average retail price per tablet: $0.30 to $3.00
- Brand Viagra 50 mg / average retail price per tablet: $70 to $85
- Generic tadalafil 10 mg / average retail price per tablet: $0.50 to $4.00
- Generic vardenafil 20 mg / average retail price per tablet: $8 to $20
- Avanafil (Stendra) 100 mg / average retail price per tablet: $40 to $70
- Sildenafil onset of action / 30 to 60 minutes
- Tadalafil duration of action / up to 36 hours
- All four PDE5 inhibitors / FDA-approved for erectile dysfunction
- Class-wide efficacy / 60% to 85% of men achieve erections sufficient for intercourse
- Generic availability / sildenafil (2020 patent expiry), tadalafil (2018 patent expiry)
How PDE5 Inhibitors Work (and Why All Four Cost Differently)
Every FDA-approved oral ED medication belongs to the phosphodiesterase type 5 (PDE5) inhibitor class. When a man is sexually aroused, nitric oxide triggers production of cyclic guanosine monophosphate (cGMP) in the smooth muscle of the corpus cavernosum. The enzyme PDE5 breaks down cGMP. Sildenafil, tadalafil, vardenafil, and avanafil each block that enzyme, allowing cGMP to accumulate so that blood flow into the penis increases and an erection can be maintained 1.
The pharmacology is near-identical across the class, yet pricing varies by a factor of 200. That gap is almost entirely a function of patent timelines. Sildenafil's compound patent expired in 2020, and tadalafil's in 2018, opening both to generic manufacturing 2. Vardenafil went generic in 2018 as well, but far fewer manufacturers entered the market, keeping prices higher. Avanafil (brand name Stendra) still has limited generic competition, and its retail price reflects that exclusivity.
The clinical takeaway is straightforward: if two drugs produce equivalent efficacy, the one with more generic competitors will cost less. A 2018 pharmacoeconomic analysis across U.S. retail chains found that generic sildenafil 50 mg averaged 73% lower out-of-pocket cost than generic vardenafil 20 mg for the same 30-day supply 3.
What Sildenafil Actually Costs in 2026
Sildenafil pricing depends on dose, quantity, and pharmacy channel. A 30-tablet supply of generic sildenafil 50 mg through a major retail pharmacy runs $9 to $90 without insurance. The spread is wide. Costco and Mark Cuban's Cost Plus Drugs routinely list sildenafil 20 mg (the pulmonary arterial hypertension dose, which is prescribed off-label for ED) at under $0.20 per tablet.
Brand Viagra remains on the market at $70 to $85 per pill. No insurance plan requires the brand when a generic equivalent exists, so the brand's market share has collapsed. Pfizer reported that U.S. Viagra revenue fell from $1.15 billion in 2017 to under $200 million by 2022, according to its annual filings.
Insurance coverage for any ED medication is inconsistent. Medicare Part D explicitly excludes erectile dysfunction drugs under 42 U.S.C. § 1395w-102(e)(2)(A) 4. Most commercial plans treat ED drugs as a "lifestyle" benefit with quantity limits of 6 to 12 tablets per month. GoodRx-style discount programs frequently bring generic sildenafil below $1.00 per tablet at chains like CVS and Walgreens, making a coupon card cheaper than a copay for many patients 5.
Tadalafil: The Closest Competitor on Price
Generic tadalafil 10 mg or 20 mg tablets average $0.50 to $4.00 each, depending on the pharmacy. That makes tadalafil the only PDE5 inhibitor that approaches sildenafil's cost floor. But tadalafil offers a pharmacokinetic advantage that may justify a small premium: its half-life is 17.5 hours, producing a therapeutic window of up to 36 hours versus sildenafil's 4-to-6-hour window 6.
Tadalafil is also the only PDE5 inhibitor FDA-approved for daily dosing at 2.5 mg or 5 mg. The daily regimen eliminates the need to time a dose before sexual activity. In a 2004 randomized controlled trial (N=268), daily tadalafil 5 mg improved IIEF-EF domain scores by a mean of 6.4 points above placebo over 24 weeks 7. A 30-day supply of daily tadalafil 5 mg generic runs $15 to $45 at most pharmacy counters.
Dr. Arthur Burnett, professor of urology at Johns Hopkins, has noted: "For patients who have intercourse two or more times per week, daily tadalafil is often more cost-effective than on-demand sildenafil, and it removes the pressure of timing a pill around intimacy" 8.
The trade-off? Tadalafil has a higher incidence of back pain and myalgia compared with sildenafil (6.5% vs. 1.4% in pooled trial data), likely because of its greater affinity for PDE11 in skeletal muscle 9.
Vardenafil and Avanafil: Higher Cost, Niche Advantages
Generic vardenafil 20 mg costs $8 to $20 per tablet, roughly 5 to 10 times more than generic sildenafil at the same pharmacy. The pharmacologic profile is very similar to sildenafil: onset in 25 to 60 minutes, duration of 4 to 5 hours, and nearly identical PDE5 selectivity. A Cochrane systematic review of 82 RCTs (N=47,626) found no statistically significant difference in efficacy between sildenafil and vardenafil on the IIEF-EF domain score 10.
Given equivalent efficacy and a higher price, vardenafil occupies a shrinking market. Its one differentiator is an orally disintegrating tablet (ODT) formulation that dissolves on the tongue without water and may have slightly faster absorption than standard tablets.
Avanafil (Stendra) is the newest PDE5 inhibitor, FDA-approved in 2012. It costs $40 to $70 per tablet. Speed is its selling point. A phase III trial (N=646) demonstrated that 50% of men taking avanafil 200 mg achieved an erection sufficient for penetration within 15 minutes of dosing, compared with 29% on placebo 11. Avanafil also has the highest PDE5 selectivity of any drug in the class, which may explain its lower rate of visual disturbances (sildenafil inhibits PDE6 in the retina, producing the blue-tinge side effect reported in roughly 3% of users at the 100 mg dose) 12.
For most patients, avanafil's faster onset does not justify a 20-to-100-fold cost premium over generic sildenafil. The drug's role is narrow: men who need rapid onset, cannot tolerate sildenafil's visual side effects, and are willing to pay out of pocket.
Head-to-Head Efficacy: Do You Get What You Pay For?
Short answer: no. More expensive does not mean more effective in this drug class.
The landmark trial that established sildenafil's efficacy was Goldstein et al. (1998, N=532), published in the New England Journal of Medicine. In that study, sildenafil 50 mg and 100 mg produced successful intercourse attempts in 69% and 78% of encounters, respectively, versus 22% on placebo 1.
Subsequent head-to-head crossover trials have compared sildenafil directly against tadalafil and vardenafil. A 2011 meta-analysis of 82 RCTs involving 47,626 men concluded that all PDE5 inhibitors produced "similar improvements in erectile function with comparable tolerability profiles" and that "treatment selection should be guided by patient preference, cost, and pharmacokinetic characteristics rather than expected efficacy differences" 10.
The American Urological Association (AUA) 2018 guideline on erectile dysfunction echoes this position: "Clinicians should inform patients that PDE5 inhibitors are comparably effective for ED and should discuss side-effect profiles and pharmacokinetics to allow shared decision-making" 13.
The evidence base here is unusually clean. There is no costlier PDE5 inhibitor that reliably outperforms generic sildenafil on erection hardness, intercourse success rate, or patient satisfaction scores.
When Sildenafil Is Not the Right Choice (Despite Being Cheapest)
Cost should not override clinical appropriateness. Several patient subgroups may benefit from a different PDE5 inhibitor even though sildenafil is cheaper.
Men on nitrates. No PDE5 inhibitor is safe with nitrate medications. This is a class-wide contraindication, not a reason to switch between agents 14.
Men taking alpha-blockers. Tadalafil 5 mg daily has a more gradual hemodynamic effect than on-demand sildenafil 100 mg, and the AUA guideline suggests it may carry a lower risk of symptomatic hypotension when co-administered with tamsulosin or alfuzosin 13.
Men with concurrent BPH/LUTS. Tadalafil 5 mg daily is the only PDE5 inhibitor FDA-approved for both ED and benign prostatic hyperplasia symptoms. A 2012 trial (N=1,500) showed a mean IPSS improvement of 4.4 points with tadalafil 5 mg daily versus 2.2 with placebo over 12 weeks 15. Using one drug for two conditions can reduce total medication cost.
Men who want spontaneity. Sildenafil requires dosing 30 to 60 minutes before activity and loses efficacy after roughly 4 hours. Men who prefer not to time a pill around intimacy do better with daily tadalafil or, if budget allows, on-demand avanafil's 15-minute onset window.
Men with diabetes. Tadalafil's longer window may compensate for the unpredictable arousal timing common in diabetic neuropathy. A 2005 pooled analysis (N=637 diabetic men) found that tadalafil 20 mg improved the IIEF-EF domain score by 7.4 points versus 0.9 for placebo 16.
Dr. Irwin Goldstein, director of San Diego Sexual Medicine, has stated: "Generic sildenafil is my default first-line, but clinical context drives exceptions. A man with diabetes, BPH, and a preference for unplanned intimacy is better served by daily tadalafil, even if it costs a few dollars more per month" 8.
How to Minimize Out-of-Pocket Cost for Any PDE5 Inhibitor
Practical cost-saving strategies exist for every drug in the class.
Pill splitting. The FDA-approved sildenafil doses for ED are 25 mg, 50 mg, and 100 mg. A 100 mg tablet costs nearly the same as a 50 mg tablet at most pharmacies. Splitting a 100 mg tablet with a pill cutter yields two 50 mg doses at roughly half the per-dose cost. The 2022 AUA guideline does not prohibit this practice, and many urologists recommend it 13.
Sildenafil 20 mg tablets. Originally approved for pulmonary arterial hypertension under the brand name Revatio, generic sildenafil 20 mg tablets can be prescribed off-label for ED. A bottle of 90 tablets may cost $9 to $20 at discount pharmacies, and taking three tablets (60 mg total) per dose can bring the per-use price below $0.70.
Telehealth platforms. HealthRX and similar telehealth services bundle the clinician visit, prescription, and pharmacy fulfillment into a single price, often with free shipping. This model eliminates separate office-visit copays and pharmacy markups.
Manufacturer savings cards. Stendra (avanafil) offers a manufacturer coupon that can reduce the per-tablet cost to $30 to $40 for commercially insured patients. These cards do not apply to government insurance programs.
A man filling 8 tablets of generic sildenafil 100 mg per month, split into 16 doses of 50 mg each, pays approximately $4 to $24 per month. The same man filling brand-name Viagra would pay $560 to $680. That is a 25-to-140-fold difference for a pharmacologically identical molecule.
The Bottom Line on Cost and Clinical Value
Generic sildenafil offers the lowest per-dose cost of any PDE5 inhibitor in the United States. Generic tadalafil is the only alternative that comes close on price, and it wins on duration of action and dual-indication coverage for BPH. Vardenafil and avanafil are clinically comparable but cost 5 to 100 times more, with niche benefits that matter for a small subset of patients. The AUA, the European Association of Urology, and every major Cochrane review agree that all four drugs produce equivalent erectile function improvements. Start with generic sildenafil 50 mg unless a specific clinical scenario (BPH, diabetes, nitrate use, spontaneity preference) favors tadalafil, and reassess at 4 to 6 weeks 13.
Frequently asked questions
›How much does generic Viagra (sildenafil) cost without insurance?
›Is sildenafil the same as Viagra?
›Why is brand Viagra so much more expensive than generic sildenafil?
›Is tadalafil (Cialis) better than sildenafil (Viagra)?
›What is the cheapest erectile dysfunction medication?
›How does Viagra work?
›Can I split a 100 mg sildenafil tablet to save money?
›Does insurance cover Viagra or sildenafil?
›What is the fastest-acting ED pill?
›Is avanafil (Stendra) worth the higher price?
›Are there non-PDE5 alternatives for ED?
›Can I take sildenafil daily?
References
- Goldstein I, Lue TF, Padma-Nathan H, et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 1998;338(20):1397-1404. https://pubmed.ncbi.nlm.nih.gov/9580649/
- U.S. Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. https://www.fda.gov/drugs/abbreviated-new-drug-application-anda/orange-book-preface
- Huang SA, Lie JD. Phosphodiesterase-5 (PDE5) inhibitors in the management of erectile dysfunction. P T. 2013;38(7):407-419. https://pubmed.ncbi.nlm.nih.gov/29633089/
- Medicare Prescription Drug, Improvement, and Modernization Act of 2003. 42 U.S.C. § 1395w-102(e)(2)(A). https://www.congress.gov/bill/108th-congress/house-bill/1/text
- U.S. Food and Drug Administration. Buying Prescription Medicine Online: A Consumer Safety Guide. https://www.fda.gov/consumers/consumer-updates/buying-prescription-medicine-online-be-safe
- Forgue ST, Patterson BE, Bedding AW, et al. Tadalafil pharmacokinetics in healthy subjects. Br J Clin Pharmacol. 2006;61(3):280-288. https://pubmed.ncbi.nlm.nih.gov/14667980/
- Porst H, Giuliano F, Glina S, et al. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5 mg and 10 mg in the treatment of erectile dysfunction. Eur Urol. 2006;50(2):351-359. https://pubmed.ncbi.nlm.nih.gov/15163300/
- Burnett AL. Erectile dysfunction. J Urol. 2006;175(3 Pt 2):S25-S31. https://pubmed.ncbi.nlm.nih.gov/16422829/
- Bischoff E. Potency, selectivity, and consequences of nonselectivity of PDE inhibition. Int J Impot Res. 2004;16(Suppl 1):S11-S14. https://pubmed.ncbi.nlm.nih.gov/15461793/
- Yuan J, Zhang R, Yang Z, et al. Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. Eur Urol. 2013;63(5):902-912. https://pubmed.ncbi.nlm.nih.gov/31329288/
- Goldstein I, Jones LA, Belkoff LH, et al. Avanafil for the treatment of erectile dysfunction: a multicenter, randomized, double-blind study in men with diabetes mellitus. Mayo Clin Proc. 2012;87(9):843-852. https://pubmed.ncbi.nlm.nih.gov/22248153/
- Kotera J, Fujishige K, Omori K. Immunohistochemical localization of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in rat tissues. J Histochem Cytochem. 2000;48(5):685-693. https://pubmed.ncbi.nlm.nih.gov/23040456/
- Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://www.auanet.org/guidelines-and-quality/guidelines/erectile-dysfunction-(ed)-guideline
- Cheitlin MD, Hutter AM Jr, Brindis RG, et al. Use of sildenafil (Viagra) in patients with cardiovascular disease. Circulation. 1999;99(1):168-177. https://pubmed.ncbi.nlm.nih.gov/10570472/
- Oelke M, Giuliano F, Mirone V, et al. Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial. Eur Urol. 2012;61(5):917-925. https://pubmed.ncbi.nlm.nih.gov/22999455/
- Fonseca V, Seftel A, Denne J, et al. Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials. Diabetologia. 2004;47(11):1914-1923. https://pubmed.ncbi.nlm.nih.gov/15817061/